| Dr Robert Blake Johnson, PHARMD | |
|
2425 Dave Ward Dr Ste 602, Conway, AR 72034-8685 | |
| (501) 336-8188 | |
| Not Available |
| Full Name | Dr Robert Blake Johnson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2425 Dave Ward Dr Ste 602, Conway, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043819923 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD12300 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Blake Johnson, PHARMD 1400 Crosspoint Rd, Conway, AR 72034-8422 Ph: () - | Dr Robert Blake Johnson, PHARMD 2425 Dave Ward Dr Ste 602, Conway, AR 72034-8685 Ph: (501) 336-8188 |
News Archive
Cancer of the pancreas is usually not detected until it's too late to cure. But precursor lesions that form in the pancreas and its ducts can signal the disease before it strikes, and when caught early enough, they can be prevented from progressing to become cancer.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced its Central Coding™ application has become the first product to achieve certification by the Uppsala Monitoring Center (UMC). Launched today ("Uppsala Monitoring Centre Launches Software Certification Program for WHO Drug Dictionary Enhanced"), UMC's new certification is designed to help software developers quickly and easily integrate the WHO Drug Dictionary Enhanced.
GTx, Inc. announced today that in the Phase III clinical trial evaluating toremifene 80 mg for the reduction of fractures and treatment of other estrogen deficiency side effects in men with prostate cancer on androgen deprivation therapy (ADT), toremifene treatment demonstrated an improved benefit/risk ratio in men less than 80 years of age. The data were presented yesterday at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago.
Researchers around the globe are working on turning microRNAs, over 5,000 of which already have been identified, into novel drugs for a wide range of applications, reports Genetic Engineering & Biotechnology News (GEN). These noncoding single-stranded RNAs act through binding to complementary mRNA sequences, thus preventing their translation into protein or accelerating mRNA breakdown, according to the March 15 issue of GEN.
› Verified 7 days ago
Dr. Hannah Elizabeth Parks, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 505 Salem Rd, Conway, AR 72034 Phone: 501-328-3117 | |
Charles Andrew Isely, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Oak St, Conway, AR 72032 Phone: 501-329-0795 | |
Kristina Erbach, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2302 College Ave, Conway, AR 72034 Phone: 501-513-5152 | |
David William Smith, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2425 Dave Ward Dr, Ste. 602, Conway, AR 72034 Phone: 501-329-3777 | |
Analia Tressa De Caro, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3430 Irby Dr, Apt. 304, Conway, AR 72034 Phone: 501-327-0510 | |
Ryan Brown, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2302 College Ave, Conway, AR 72034 Phone: 501-513-5152 |